N-(1-Phenylisopropyl)-N-methylprop-2-inylamin | 2323-35-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(1-Phenylisopropyl)-N-methylprop-2-inylamin
• 英文别名: N-(phenylisopropyl)-N-methyl-propargylamine；N-methyl-2-phenyl-N-prop-2-ynylpropan-2-amine
• CAS: 2323-35-5
• 化学式: C₁₃H₁₇N
• 分子量: 187.285
• InChiKey: VSKMBAUXHAEDAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• CYTOPROTECTIVE AGENTS COMPRISING MONOAMINE OXIDASE INHIBITORS
  申请人：THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

  公开号：EP0975366A1

  公开（公告）日：2000-02-02
• INFUSION AND INJECTION SOLUTION OF LEVODOPA
  申请人：Dizlin Medical Design AB

  公开号：EP1773297B1

  公开（公告）日：2015-01-14
• DEVICE AND METHOD FOR DELIVERING AN INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USER
  申请人：Vibrant Ltd.

  公开号：EP3906086A1

  公开（公告）日：2021-11-10
• DEVICE AND METHOD FOR DELIVERING A FLOWABLE INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USER
  申请人：Vibrant Ltd.

  公开号：EP3914332A2

  公开（公告）日：2021-12-01
• [EN] CYTOPROTECTIVE AGENTS COMPRISING MONOAMINE OXIDASE INHIBITORS<br/>[FR] AGENTS CYTOPROTECTEURS COMPRENANT DES INHIBITEURS DE MONOAMINE-OXYDASE
  申请人：THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

  公开号：WO1998040102A1

  公开（公告）日：1998-09-17

  (EN) The present invention concerns the use of monoamine oxidase (MAO) inhibitors in the protection or rescue of normal cells from the toxic side effects caused by irradiation or the administration of chemotherapeutic agents such as certain anti-cancer agents. Deprenyl is a particularly preferred MAO inhibitor.(FR) La présente invention concerne l'utilisation d'inhibiteurs de la monoamine-oxydase (MAO), dans la protection ou le sauvetage de cellules normales contre les effets secondaires toxiques provoqués par une irradiation ou l'administration d'agents chimiothérapeutiques tels que certains agents anti-cancéreux. Le déprényle est un inhibiteur de MAO particulièrement préféré.